Type 2 Diabetes
Type 2 diabetes is primarily a disorder in which the cells in the body are not responding to the high levels of insulin circulating in the body. The body becomes increasingly resistant to insulin. In end-stage type 2 diabetes, the beta cells of the pancreas are not producing enough insulin.Insulin is a hormone normally produced by the pancreas. This hormone helps your body convert food into energy. Without insulin, glucose (sugar) from the food you eat cannot enter cells, and glucose builds up in the blood. Your body tissues become starved for energy.
How Type 2 Diabetes Occurs
© 2011 Nucleus Medical Media, Inc.
Diabetes affects an estimated 25.8 million Americans, with type 2 diabetes being the most common form. People usually develop this condition after age 45, but it can occur at any age—even during childhood.
In recent years, there has been an increase in the number of cases of type 2 diabetes diagnosed in children and adolescents. This has been blamed, in part, on the increase in childhood obesity, resulting from poor eating habits and sedentary lifestyle.
Type 2 diabetes occurs because either one or both of the following conditions exist:
- Beta cells in the pancreas do not make enough insulin relative to the demands of the body
- Fat, muscle, or liver cells do not respond to the high levels of insulin (called insulin resistance)
The key to minimizing complications is keeping your blood sugar level within a healthy range. When your blood sugar level is not within the ideal range, you can experience the following problems:
- In the short-term:
- High blood sugar (hyperglycemia)
- Low blood sugar (hypoglycemia)
- In the long-term:
- Blindness
- Kidney disease
- Heart disease
- Stroke
- Nerve disease (can cause numbness, pain, or altered sensation, such as a burning feeling in the legs and feet)
- Loss of limbs (when amputations are needed because of infection, poor circulation, or nerve disease)
- Impotence
REFERENCES:
American Diabetes Association website. Available at: http://www.diabetes.org . Accessed February 11, 2010.National diabetes statistics, 2007. National Diabetes Information Clearinghouse website. Available at: http://diabetes.niddk.nih.gov/DM/PUBS/statistics/ . Published June 2008. Accessed February 11, 2010.
National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health website. Available at: http://www.niddk.nih.gov/ . Accessed February 11, 2010.
Rosenbloom AL, Silverstein JH, Amemiya S, et al. ISPAD clinical practice consensus guideline 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008;9:512-526.
Rosenzweig JL, Ferrannini E, Grundy SM, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab.2008;93:3671-3689.
Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE and VA diabetes trials: a position statement of the American Diabetes association and a scientific statement of the American College of Cardiology Foundation and the American Heart Assocaition. Circulation. 2009;119:351-357.
United States Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults. Ann Intern Med.2008;148:846-54.
1/28/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php : National Diabetes fact shee, 2011. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf . Published January 2011. Accessed January 28, 2011.
Copyright © 2010 EBSCO Publishing All rights reserved.
No comments:
Post a Comment